Nicholas Glover, CEO and President at ProNAi Therapeutics Inc (DNAI), sold 10,000 shares at $10.04 ($100K) on 2016-01-15, disclosed to the SEC on 2016-01-19.
Open-market sale of $100k DNAI by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.04 | 5,000 | $50K | 50.0% |
| 2 | $10.04 | 5,000 | $50K | 50.0% |
| Total | $10.04 avg | 10,000 | $100K | 100% |